FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3186566735> ?p ?o ?g. }

• W3186566735 endingPage "8516" @default.
• W3186566735 startingPage "8500" @default.
• W3186566735 abstract "Rationale: Bak is a major proapoptotic Bcl2 family member and a required molecule for apoptotic cell death. High levels of endogenous Bak were observed in both small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) cell lines. Increased Bak expression was correlated with poor prognosis of NSCLC patients, suggesting that Bak protein is an attractive target for lung cancer therapy. The BH3 domain functions as death domain and is required for Bak to initiate apoptotic cell death. Thus, the BH3 domain is attractive target for discovery of Bak agonist. Methods: The BH3 death domain binding pocket (aa75-88) of Bak was chosen as a docking site for screening of small molecule Bak activators using the UCSF DOCK 6.1 program suite and the NCI chemical library (300,000 small molecules) database. The top 500 compounds determined to have the highest affinity for the BH3 domain were obtained from the NCI and tested for cytotoxicity for further screening. We identified a small molecule Bak activator BKA-073 as the lead compound. The binding affinity of BKA-073 with Bak protein was analyzed by isothermal titration calorimetry (ITC) assay. BKA-073-mediated Bak activation via oligomerization was analyzed by a cross-linking with Bis (maleimido) hexane (BMH). Sensitivity of BKA-073 to lung cancer cells in vitro was evaluated by dynamic BH3 profiling (DBP) and apoptotic cell death assay. The potency of BKA-073 alone or in combination with radiotherapy or Bcl2 inhibitor was evaluated in animal models. Results: We found that BKA-073 binds Bak at BH3 domain with high affinity and selectivity. BKA-073/Bak binding promotes Bak oligomerization and mitochondrial priming that activates its proapoptotic function. BKA-073 potently suppresses tumor growth without significant normal tissue toxicity in small cell lung cancer (SCLC) and NSCLC xenografts, patient-derived xenografts, and genetically engineered mouse models of mutant KRAS-driven cancer. Bak accumulates in radioresistant lung cancer cells and BKA-073 reverses radioresistance. Combination of BKA-073 with Bcl-2 inhibitor venetoclax exhibits strong synergy against lung cancer in vivo. Conclusions: Development of small molecule Bak activator may provide a new class of anticancer agents to treat lung cancer." @default.
• W3186566735 created "2021-08-02" @default.
• W3186566735 creator A5002430008 @default.
• W3186566735 creator A5012015166 @default.
• W3186566735 creator A5015060656 @default.
• W3186566735 creator A5015097085 @default.
• W3186566735 creator A5023971012 @default.
• W3186566735 creator A5035235955 @default.
• W3186566735 creator A5035252203 @default.
• W3186566735 creator A5057870036 @default.
• W3186566735 creator A5077115512 @default.
• W3186566735 creator A5082568708 @default.
• W3186566735 creator A5088178599 @default.
• W3186566735 date "2021-01-01" @default.
• W3186566735 modified "2023-10-14" @default.
• W3186566735 title "Discovery of Small Molecule Bak Activator for Lung Cancer Therapy" @default.
• W3186566735 cites W1489687934 @default.
• W3186566735 cites W1793209228 @default.
• W3186566735 cites W1834626755 @default.
• W3186566735 cites W1913661233 @default.
• W3186566735 cites W1943613220 @default.
• W3186566735 cites W1967194777 @default.
• W3186566735 cites W1980497534 @default.
• W3186566735 cites W1980597642 @default.
• W3186566735 cites W1984547206 @default.
• W3186566735 cites W1984636849 @default.
• W3186566735 cites W1994772304 @default.
• W3186566735 cites W1998971866 @default.
• W3186566735 cites W2000530224 @default.
• W3186566735 cites W2009333774 @default.
• W3186566735 cites W2012835470 @default.
• W3186566735 cites W2017986614 @default.
• W3186566735 cites W2027542963 @default.
• W3186566735 cites W2032366675 @default.
• W3186566735 cites W2050389860 @default.
• W3186566735 cites W2053277232 @default.
• W3186566735 cites W2059340786 @default.
• W3186566735 cites W2065942364 @default.
• W3186566735 cites W2071182159 @default.
• W3186566735 cites W2075924209 @default.
• W3186566735 cites W2080842490 @default.
• W3186566735 cites W2082055490 @default.
• W3186566735 cites W2085419794 @default.
• W3186566735 cites W2098876426 @default.
• W3186566735 cites W2105594055 @default.
• W3186566735 cites W2106787323 @default.
• W3186566735 cites W2108972249 @default.
• W3186566735 cites W2116177527 @default.
• W3186566735 cites W2119316461 @default.
• W3186566735 cites W2126709547 @default.
• W3186566735 cites W2134964552 @default.
• W3186566735 cites W2135137229 @default.
• W3186566735 cites W2135617839 @default.
• W3186566735 cites W2146409593 @default.
• W3186566735 cites W2154572127 @default.
• W3186566735 cites W2155289066 @default.
• W3186566735 cites W2157805786 @default.
• W3186566735 cites W2158025958 @default.
• W3186566735 cites W2158467294 @default.
• W3186566735 cites W2162123587 @default.
• W3186566735 cites W2165056381 @default.
• W3186566735 cites W2346657770 @default.
• W3186566735 cites W2395354830 @default.
• W3186566735 cites W2517675534 @default.
• W3186566735 cites W2522678060 @default.
• W3186566735 cites W2527910211 @default.
• W3186566735 cites W2584838045 @default.
• W3186566735 cites W2605095179 @default.
• W3186566735 cites W2767246174 @default.
• W3186566735 cites W2775609536 @default.
• W3186566735 cites W2785870654 @default.
• W3186566735 cites W2792666902 @default.
• W3186566735 cites W2904585190 @default.
• W3186566735 cites W2911188335 @default.
• W3186566735 cites W2917837889 @default.
• W3186566735 cites W2922692686 @default.
• W3186566735 cites W2923741872 @default.
• W3186566735 cites W2942636629 @default.
• W3186566735 cites W2944081322 @default.
• W3186566735 cites W2945338000 @default.
• W3186566735 cites W2405345539 @default.
• W3186566735 doi "https://doi.org/10.7150/thno.60349" @default.
• W3186566735 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8344021" @default.
• W3186566735 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34373755" @default.
• W3186566735 hasPublicationYear "2021" @default.
• W3186566735 type Work @default.
• W3186566735 sameAs 3186566735 @default.
• W3186566735 citedByCount "14" @default.
• W3186566735 countsByYear W31865667352021 @default.
• W3186566735 countsByYear W31865667352022 @default.
• W3186566735 countsByYear W31865667352023 @default.
• W3186566735 crossrefType "journal-article" @default.
• W3186566735 hasAuthorship W3186566735A5002430008 @default.
• W3186566735 hasAuthorship W3186566735A5012015166 @default.
• W3186566735 hasAuthorship W3186566735A5015060656 @default.
• W3186566735 hasAuthorship W3186566735A5015097085 @default.
• W3186566735 hasAuthorship W3186566735A5023971012 @default.
• W3186566735 hasAuthorship W3186566735A5035235955 @default.

• next